cutaneous lupus erythematosus

An autoimmune disease in which the immune system attacks its healthy skin, Cutaneous Lupus Erythematosus, belongs to the family of Lupus Erythematosus (LE). Cutaneous Lupus Erythematosus (CLE) is a form of lupus that primarily affects the skin, either as a standalone condition or in conjunction with systemic lupus erythematosus (SLE). While SLE can involve multiple organs, CLE is mostly limited to dermatological symptoms and lesions. It is considered an autoimmune disease, meaning the body’s immune system mistakenly attacks its own tissues, particularly the skin.

Through the newsletter, DelveInsight brings to light about a condition that had a prevalence of 327,569 in the US alone in 2017.

The newsletter provides an overview of the indication, symptoms, causes, and etiology. It also put forward the historical epidemiological trends listing its prevalence and incidence, with the 11-year forecast. The newsletter also covers the present market scenario and the companies that are working to shift the CL market in the coming decade with key collaborations, and partnerships along with top conferences that are going to take place in the following year.

Download the newsletter by filling the form and get access to rich insights into CLE market trends.

For more such analytical information directly delivered to your inbox, join DelveInsight's emailer list and gain a competitive edge.

Stay in the loop.